C Cordivari, VP Misra, S Catania, AJ Lees - Movement Disorders, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 29 - Related articles - BL Direct - All 3 versions
DD Truong, WH Jost - Parkinsonism & Related Disorders, 2006 - Elsevier In 1897, Emile van Ermengem investigated an epidemic in Ellezelles, Belgium,
where several people who had gathered at a funeral music festival developed
botulism after consuming raw ham [1]. After isolating the bacteria from the ... Cited by 28 - Related articles - All 14 versions
DE Kyrmizakis, A Pangalos, CE Papadakis, J … - Journal of Oral and Maxillofacial Surgery, 2004 - Elsevier We sought to investigate the efficacy of botulinum toxin type A in the treatment
of Frey and crocodile tears syndromes. Frey syndrome is a common complication
after surgical intervention or injury in the region of the parotid gland. ... Cited by 29 - Related articles - All 12 versions
JJ Dutton, AM Fowler - Survey of ophthalmology, 2007 - Elsevier Since its introduction into clinical medicine in 1980, botulinum toxin has
become a major therapeutic drug with applications valuable to many medical
sub-specialties. Its use was spearheaded in ophthalmology where its ... Cited by 17 - Related articles - All 12 versions
KW Whittaker, BN Matthews, AW Fitt, S … - Orbit, 2003 - informahealthcare.com Acknowledgements: Presented as a paper at the European Society of Ophthalmic
Plastic and Reconstructive Surgery, Santiago de Compostela, Spain, June 2001.
The Botulinum toxin A (BOTOX®) was provided free of charge by Allergan®. ... Cited by 11 - Related articles - BL Direct - All 5 versions
B Bentsianov, C Zalvan, A Blitzer - Clinics in dermatology, 2004 - Elsevier Since the introduction of botulinum toxin (BTX) as a therapeutic tool in the
1970s, the number of uses for this substance has increased exponentially. BTX's
mechanism of action involves degrading the SNARE proteins blockading the ... Cited by 11 - Related articles - All 13 versions
I Rahman, SA Sadiq - Survey of ophthalmology, 2007 - Elsevier Facial nerve palsy affects individuals of all ages, races, and sexes.
Psychological and functional implications of the paralysis present a devastating
management problem to those afflicted, as well as the carriers. Since Sir ... Cited by 9 - Related articles - All 14 versions
CNCM FRCOphth, FQM BmedSc, EJ MRCOphth … - Orbit, 2004 - informahealthcare.com Abstract purpose To assess the effect and efficacy of botulinum toxin type A
(BTX-A) at reducing and maintaining eyelid synkinesia in aberrant facial nerve
regeneration, while concurrently observing for the pres- ence of side ... Cited by 8 - Related articles - All 5 versions
- ►iovs.org O Suwan-apichon, M Rizen, R Rangsin, S … - Investigative ophthalmology & visual science, 2006 - ARVO METHODS. Under direct visualization with an operating microscope, CBA/J mice
received a transconjunctival injection of saline or 1.25, 5, or 20 milliunits
(mU) of botulinum toxin B (BTX-B) into the lacrimal gland. The mice were ... Cited by 8 - Related articles - BL Direct - All 3 versions
- ►bmj.com [PDF] DE Baranano, NR Miller - British Medical Journal, 2004 - bjo.bmj.com Mixed infection (Pseudomonas and coagulase negative staphylococci) microbial
keratitis associated with extended wear silicone hydrogel contact lens Contact
lens induced ulcerative keratitis is a serious complication which can be ... Cited by 7 - Related articles - All 8 versions
